Ismat Lotia Farrukh, Nathalie Lachenal, Malik M Adenov, Saman Ahmed, Yerkebulan Algozhin, Sylvine Coutisson, Epifanio Sánchez Garavito, Catherine Hewison, David Holtzman, Helena Huerga, Aleeza Janmohamed, Palwasha Y Khan, Gamarly Leblanc Jacques, Nino Lomtadze, Nara Melikyan, Carole D Mitnick, Gulnaz Mussabekova, Elna Osso, Sara Perea, Fauziah Asnely Putri, Mahmud Rashidov, Michael L Rich, Yekaterina Sakhabutdinova, Kwonjune J Seung, Assel Stambekova, Dante Vargas Vásquez, Molly F Franke, Uzma Khan
Among 43 pregnant women receiving multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment with bedaquiline and/or delamanid, 98% had favorable treatment outcomes. Of 31 continued pregnancies, 81% had live births with no reported malformations, and 68% of neonates had normal birth weights. Effective MDR/RR-TB treatment during pregnancy can improve maternal outcomes without harming neonates.
August 22, 2023: Clinical Infectious Diseases